AU2001295098A1 - Monoclonal antibody against ovarian carcinoma - Google Patents
Monoclonal antibody against ovarian carcinomaInfo
- Publication number
- AU2001295098A1 AU2001295098A1 AU2001295098A AU9509801A AU2001295098A1 AU 2001295098 A1 AU2001295098 A1 AU 2001295098A1 AU 2001295098 A AU2001295098 A AU 2001295098A AU 9509801 A AU9509801 A AU 9509801A AU 2001295098 A1 AU2001295098 A1 AU 2001295098A1
- Authority
- AU
- Australia
- Prior art keywords
- monoclonal antibody
- antibody against
- ovarian carcinoma
- against ovarian
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010033128 Ovarian cancer Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA2000/2782 | 2000-09-05 | ||
| ZA200002782 | 2000-09-05 | ||
| PCT/ZA2001/000132 WO2002020620A2 (en) | 2000-09-05 | 2001-09-04 | Monoclonal antibody against ovarian carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001295098A1 true AU2001295098A1 (en) | 2002-03-22 |
Family
ID=25588774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001295098A Abandoned AU2001295098A1 (en) | 2000-09-05 | 2001-09-04 | Monoclonal antibody against ovarian carcinoma |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US7229780B2 (en) |
| AU (1) | AU2001295098A1 (en) |
| WO (1) | WO2002020620A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1568698A1 (en) | 2004-02-27 | 2005-08-31 | Aventis Pharma Deutschland GmbH | Pyrrole-derivatives as factor Xa inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059680A (en) | 1986-11-24 | 1991-10-22 | Centocor, Inc. | Method of isolating ca 125 antigen |
| WO1989001629A1 (en) * | 1987-08-19 | 1989-02-23 | Centocor, Inc. | Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
-
2001
- 2001-09-04 WO PCT/ZA2001/000132 patent/WO2002020620A2/en not_active Ceased
- 2001-09-04 US US10/488,774 patent/US7229780B2/en not_active Expired - Fee Related
- 2001-09-04 AU AU2001295098A patent/AU2001295098A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7229780B2 (en) | 2007-06-12 |
| US20040259174A1 (en) | 2004-12-23 |
| WO2002020620A2 (en) | 2002-03-14 |
| WO2002020620A3 (en) | 2003-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002251562A1 (en) | Anti-CD40 monoclonal antibody | |
| HUP0300841A3 (en) | Agonist anti-trk-c monoclonal antibodies | |
| IL156030A0 (en) | Humanized antibodies | |
| AU1174702A (en) | Humanized anti-lt-beta-r antibodies | |
| AU2001234125A1 (en) | Antibody library | |
| AU2001268855A1 (en) | Single-domain antigen-binding antibody fragments derived from llama antibodies | |
| DE60222658D1 (en) | MONOCLONAL ANTI-CD-40 ANTIBODY | |
| AU2002256895A1 (en) | Anti-TRAIL-R antibodies | |
| AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
| AU1687500A (en) | Antihuman vegf monoclonal antibody | |
| AUPR395801A0 (en) | Antibodies against cancer | |
| AU2002365649A1 (en) | Anti-dota antibody | |
| IL136459A0 (en) | Antibody library | |
| AU2001246846A1 (en) | Immunoassay of anti-hm1.24 antibody | |
| AU4441799A (en) | Monoclonal antibodies that recognize antigens associated with tumor metastasis | |
| AU2001290860A1 (en) | Spas-1 cancer antigen | |
| AU2001246934A1 (en) | Agonist antibodies | |
| AU2002221132A1 (en) | Novel antibody | |
| AU2001295098A1 (en) | Monoclonal antibody against ovarian carcinoma | |
| EP1455822A4 (en) | Lyophilized monoclonal antibody compositions | |
| AU2002217525A1 (en) | Novel monoclonal antibody | |
| EP1446416A4 (en) | Tumor specific monoclonal antibodies | |
| AUPQ599300A0 (en) | Monoclonal antibody and uses therefor | |
| GB0029846D0 (en) | Monoclonal antibody | |
| GB0030139D0 (en) | Monoclonal antibody |